MDR1-transfection and P-glycoprotein induction studies including talinolol as P-gp probe

被引：0
|
作者：
Spahn-Langguth, H
Ofer, M
Hilgendorf, C
Langguth, P
机构：
[1] Univ Mainz, Sch Pharm, D-55099 Mainz, Germany
[2] Univ Halle Wittenberg, Sch Pharm, D-06120 Halle Saale, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2004年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
12
引用
收藏
页码：R3 / R3
页数：1
相关论文
共 50 条
  • [1] Intestinal P-glycoprotein (P-gp) Contribution to Talinolol Pharmacokinetics in Human
    Wan, Christine
    Ishida, Kazuya
    Lai, Yurong
    FASEB JOURNAL, 2022, 36
  • [2] P-glycoprotein (P-gp/MDR1)-Mediated Efflux of Sex-Steroid Hormones and Modulation of P-gp Expression In Vitro
    Winnie Y. Kim
    Leslie Z. Benet
    Pharmaceutical Research, 2004, 21 : 1284 - 1293
  • [3] P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro
    Kim, WY
    Benet, LZ
    PHARMACEUTICAL RESEARCH, 2004, 21 (07) : 1284 - 1293
  • [4] Circadian changes in intestinal secretion: Drug-drug interactions with the P-glycoprotein (P-gp) substrate talinolol
    Okyar, A.
    Baktir, G.
    Spahn-Langguth, H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2008, 377 : 62 - 62
  • [5] IS INHIBITION OF P-GLYCOPROTEIN (P-GP) SUBSTRATE DEPENDENT?
    Louie, Steven W.
    Hsiao, Peng
    Unadkat, Jashvant D.
    DRUG METABOLISM REVIEWS, 2014, 45 : 252 - 253
  • [6] THE IMPACT OF P-GLYCOPROTEIN ON THE PHARMACOKINETICS OF QUINIDINE: EVALUATION USING THE MDR1A (P-GP) KNOCKOUT RATS
    Ito, Satoshi
    Aoyama, Shinsuke
    Hashizume, Kenta
    Takao, Atsushi
    Nemoto, Hiroyuki
    Aoyama, Shinsuke
    Adachi, Yasuhisa
    Ninomiya, Shin-ichi
    DRUG METABOLISM REVIEWS, 2012, 44 : 143 - 143
  • [7] DETECTION AND LOCALIZATION OF P-GLYCOPROTEIN (P-GP) IN THE KIDNEY
    TOBE, S
    LIEBERMAN, D
    GOLDBERG, H
    SKORECKI, K
    REITHMEIER, R
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 234 - 234
  • [8] Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: Influence of cell line and modulator concentration on P-GP activity
    Taub, ME
    Podila, L
    Ely, D
    Almeida, I
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (11) : 1679 - 1687
  • [9] Influence of P-glycoprotein (P-gp) induction on the pharmacokinetics of risperidone and paliperidone in mouse brain
    Holthoewer, D.
    Hiemke, C.
    Schmitt, U.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 223 - 223
  • [10] Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies
    Mohamed Elmeliegy
    Manoli Vourvahis
    Cen Guo
    Diane D. Wang
    Clinical Pharmacokinetics, 2020, 59 : 699 - 714
12345